One study reported ventral prostate hyperplasia in estrogen receptor β−/− mice with a possible increased incidence of prostate cancer, while genetic analysis found a significant increase in CXCL17 (Wu et al., 2017). The gene discussed is CXCL17; the disease is prostate carcinoma.